
Paraneoplastic endocrine syndromes define a group of secondary signs and symptoms associated to a neoplasia, independently from the location of the primary tumor or its metastases. Paraneoplastic or ectopic endocrine syndromes usually result from aberrant hormone precursors or hormone-like substances by tumours. Knowledge of paraneoplastic endocrine complications is important both for the early diagnosis of neoplasia and the prognosis of the patient. In this review we discuss almost all reported paraneoplastic endocrine syndromes. We analyze their prevalence, etiology, laboratory diagnosis and treatment.
Puberty, Precocious, Hyperthyroidism, Hypoglycemia, Paraneoplastic Endocrine Syndromes, Diagnosis, Differential, Belgium, Hyperglycemia, Acromegaly, Hypertension, Osteomalacia, Hypercalcemia, Prevalence, Exophthalmos, Humans, Cushing Syndrome, Malignant Carcinoid Syndrome
Puberty, Precocious, Hyperthyroidism, Hypoglycemia, Paraneoplastic Endocrine Syndromes, Diagnosis, Differential, Belgium, Hyperglycemia, Acromegaly, Hypertension, Osteomalacia, Hypercalcemia, Prevalence, Exophthalmos, Humans, Cushing Syndrome, Malignant Carcinoid Syndrome
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
